AFLP-AFLP in silico-NGS approach reveals polymorphisms in repetitive elements in the malignant genome

por Koblihova, Jitka, Srutova, Klara, Krutska, Monika, Klamova, Hana, Machova Polakova, Katerina
Publicado 2018

Expression patterns of microRNAs associated with CML phases and their disease related targets

por Machová Poláková, Kateřina, Lopotová, Tereza, Klamová, Hana, Burda, Pavel, Trněný, Marek, Stopka, Tomáš, Moravcová, Jana
Publicado 2011

Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing

por Linhartova, Jana, Hovorkova, Lenka, Soverini, Simona, Benesova, Adela, Jaruskova, Monika, Klamova, Hana, Zuna, Jan, Machova Polakova, Katerina
Publicado 2015

Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment

por Humlová, Zuzana, Klamová, Hana, Janatková, Ivana, Malíčková, Karin, Králíková, Petra, Šterzl, Ivan, Roth, Zdeněk, Hamšíková, Eva, Vonka, Vladimír
Publicado 2010

Inhibition of casein kinase 2 induces cell death in tyrosine kinase inhibitor resistant chronic myelogenous leukemia cells

por Mitrovský, Ondřej, Myslivcová, Denisa, Macháčková-Lopotová, Tereza, Obr, Adam, Čermáková, Kamila, Ransdorfová, Šárka, Březinová, Jana, Klamová, Hana, Žáčková, Markéta
Publicado 2023

Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy

por Pavlík, Tomáš, Janoušová, Eva, Pospíšil, Zdeněk, Mužík, Jan, Žáčková, Daniela, Ráčil, Zdeněk, Klamová, Hana, Cetkovský, Petr, Trněný, Marek, Mayer, Jiří, Dušek, Ladislav
Publicado 2011

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment

por Jaruskova, Monika, Curik, Nikola, Hercog, Rajna, Polivkova, Vaclava, Motlova, Eliska, Benes, Vladimir, Klamova, Hana, Pecherkova, Pavla, Belohlavkova, Petra, Vrbacky, Filip, Machova Polakova, Katerina
Publicado 2017

Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in Hi...

por Polivkova, Vaclava, Rohon, Peter, Klamova, Hana, Cerna, Olga, Divoka, Martina, Curik, Nikola, Zach, Jan, Novak, Martin, Marinov, Iuri, Soverini, Simona, Faber, Edgar, Machova Polakova, Katerina
Publicado 2016

BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia

por Srutova, Klara, Curik, Nikola, Burda, Pavel, Savvulidi, Filipp, Silvestri, Giovannino, Trotta, Rossana, Klamova, Hana, Pecherkova, Pavla, Sovova, Zofie, Koblihova, Jitka, Stopka, Tomas, Perrotti, Danilo, Polakova, Katerina Machova
Publicado 2018

Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients

por Soverini, Simona, De Benedittis, Caterina, Polakova, Katerina Machova, Linhartova, Jana, Castagnetti, Fausto, Gugliotta, Gabriele, Papayannidis, Cristina, Mancini, Manuela, Klamova, Hana, Salvucci, Marzia, Crugnola, Monica, Iurlo, Alessandra, Albano, Francesco, Russo, Domenico, Rosti, Gianantonio, Cavo, Michele, Baccarani, Michele, Martinelli, Giovanni
Publicado 2016

Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining

por Curik, Nikola, Polivkova, Vaclava, Burda, Pavel, Koblihova, Jitka, Laznicka, Adam, Kalina, Tomas, Kanderova, Veronika, Brezinova, Jana, Ransdorfova, Sarka, Karasova, Dominika, Rejlova, Katerina, Bakardjieva, Marina, Kuzilkova, Daniela, Kundrat, David, Linhartova, Jana, Klamova, Hana, Salek, Cyril, Klener, Pavel, Hrusak, Ondrej, Machova Polakova, Katerina
Publicado 2021

P669: ANALYSIS OF FACTORS INFLUENCING THE DECISION TO STOP TKI TREATMENT IN CML PATIENTS IN DEEP MOLECULAR RESPONSE

por Semerad, Lukas, Žáčková, Daniela, Belohlavkova, Petra, Voglova, Jaroslava, Žák, Pavel, Faber, Edgar, Papajik, Tomas, Skoumalova, Ivana, Karas, Michal, Jindra, Pavel, Klamová, Hana, Salek, Cyril, Srbová, Dana, Zizkova, Hana, Stejskal, Lukas, Cerna, Olga, Cmunt, Eduard, Cicatkova, Petra, Kvetkova, Anezka, Hornak, Tomas, Jeziskova, Ivana, Jurcek, Tomas, Weinbergerová, Barbora, Prochazkova, Jirina, Machova Polakova, Katerina, Svobodnik, Adam, Stepanova, Radka, Mayer, Jiri
Publicado 2023

Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels

por Klamová, Hana, Poláková, Kateřina Machová, Mužík, Jan, Ráčil, Zdeněk, Žáčková, Daniela, Steinerová, Kateřina, Karas, Michal, Faber, Edgar, Demečková, Eva, Michalovičová-Sninská, Zuzana, Voglová, Jaroslava, Demitrovičová, Ľudmila, Mikušková, Eva, Tóthová, Elena, Chudej, Juraj, Markuljak, Imrich, Cmunt, Eduard, Moravcová, Jana, Dvořáková, Dana, Michalová, Kyra, Jarošová, Marie, Šťastná, Markéta Marková, Cetkovský, Petr, DuŠek, Ladislav, Koza, Vladimír, Trněný, Marek, Indrák, Karel
Publicado 2013

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy

por Salmon, Matthew, White, Helen E., Zizkova, Hana, Gottschalk, Andrea, Motlova, Eliska, Cerveira, Nuno, Colomer, Dolors, Coriu, Daniel, Franke, Georg N., Gottardi, Enrico, Izzo, Barbara, Jurcek, Tomas, Lion, Thomas, Schäfer, Vivien, Venturi, Claudia, Vigneri, Paolo, Zawada, Magdalena, Zuna, Jan, Hovorkova, Lenka, Koblihova, Jitka, Klamova, Hana, Markova, Marketa Stastna, Srbova, Dana, Benesova, Adela, Polivkova, Vaclava, Zackova, Daniela, Mayer, Jiri, Roeder, Ingo, Glauche, Ingmar, Ernst, Thomas, Hochhaus, Andreas, Polakova, Katerina Machova, Cross, Nicholas C. P.
Publicado 2022